Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Interest & Investment Income (2016 - 2025)

CorMedix's Interest & Investment Income history spans 13 years, with the latest figure at $889981.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 74.3% year-over-year to $889981.0; the TTM value through Dec 2025 reached $3.8 million, up 49.13%, while the annual FY2025 figure was $3.8 million, 49.13% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $889981.0 at CorMedix, down from $1.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.6 million in Q3 2025 and bottomed at $3022.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $478488.0 (2023), against an average of $443169.1.
  • The largest annual shift saw Interest & Investment Income crashed 94.23% in 2021 before it skyrocketed 4102.08% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $4367.0 in 2021, then surged by 4102.08% to $183505.0 in 2022, then soared by 317.01% to $765241.0 in 2023, then plummeted by 33.28% to $510592.0 in 2024, then soared by 74.3% to $889981.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Interest & Investment Income are $889981.0 (Q4 2025), $1.6 million (Q3 2025), and $828949.0 (Q2 2025).